Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb;39(2):220-5.
doi: 10.1007/s00259-011-1965-z. Epub 2011 Oct 19.

Reliability of striatal [¹¹C]raclopride binding in smokers wearing transdermal nicotine patches

Karmen K Yoder  1 , Daniel S Albrecht, David A Kareken, Lauren M Federici, Kevin M Perry, Elizabeth A Patton, Qi-Huang Zheng, Bruce H Mock, Sean J O'Connor, Christine M Herring
Affiliations

Reliability of striatal [¹¹C]raclopride binding in smokers wearing transdermal nicotine patches

Karmen K Yoder et al. Eur J Nucl Med Mol Imaging. 2012 Feb.

Abstract

Purpose: In studies where [(11)C]raclopride (RAC) positron emission tomography (PET) is used to assess changes in striatal dopamine, it is important to control for cognitive states, such as drug craving, that could alter dopamine levels. In cigarette smokers, transdermal nicotine patches (TNP) can control nicotine craving, but the effects of nicotine patches on RAC binding are unknown. Thus, we sought to determine the test-retest reliability of RAC binding in the presence of nicotine patches.

Methods: Eleven male smokers were scanned twice with RAC on separate days while wearing TNP.

Results: Across the striatum, test-retest variability was 7.63 ± 5.88; percent change in binding potential was 1.11 ± 9.83; and the intraclass correlation coefficient was 0.91 (p < 0.0001).

Conclusion: Baseline RAC binding is highly reproducible in smokers wearing nicotine patches. This suggests that TNP are an acceptable method for controlling cigarette craving during studies that utilize RAC to examine changes in dopamine.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors declare that they have no conflicts of interest.

Figures

Fig. 1
Fig. 1
General outline of study day, starting with subject arrival at ~ 8:00 a.m. All times are approximate. CWS: Cigarette Withdrawal Scale; EtOH: alcohol; MRI: magnetic resonance imaging; RAC: [11C]raclopride. Additional details are given in the text.
Fig. 2
Fig. 2
Mean ± s.d. cigarette craving ratings from Day 1 (filled circles) and Day 2 (open triangles), and Times 1, 2, and 3 (please see Figure 1 for approximate timing of ratings). The x-axis crosses the y-axis at the value of 4 to denote that 4 is the lowest possible score on the index; for reference, 20 is the highest possible score. Craving ratings did not vary within subjects across either day or time point (see text for details).
See this image and copyright information in PMC

References

    1. Egerton A, Mehta MA, Montgomery AJ, Lappin JM, Howes OD, Reeves SJ, et al. The dopaminergic basis of human behaviors: A review of molecular imaging studies. Neurosci Biobehav Rev. 2009;33:1109–32. doi: 10.1016/j.neubiorev.2009.05.005. S0149-7634(09)00077-3 [pii] - DOI - PMC - PubMed
    1. Yoder KK, Kareken DA, Morris ED. Assessing Dopaminergic Neurotransmission with PET: Basic Theory and Applications in Alcohol Research. Current Medical Imaging Reviews. 2011 in press.
    1. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab. 2000;20:423–51. - PubMed
    1. Morris ED, Yoder KK. Positron emission tomography displacement sensitivity: predicting binding potential change for positron emission tomography tracers based on their kinetic characteristics. J Cereb Blood Flow Metab. 2007;27:606–17. doi: 10.1038/sj.jcbfm.9600359. 9600359 [pii] - DOI - PubMed
    1. Yoder KK, Kareken DA, Morris ED. What were they thinking? Cognitive states may influence [(11)C]raclopride binding potential in the striatum. Neurosci Lett. 2008;430:38–42. - PMC - PubMed

Publication types